chrX-139530746-CA-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_000133.4(F9):c.-17del variant causes a 5 prime UTR change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: not found (cov: 24)
Consequence
F9
NM_000133.4 5_prime_UTR
NM_000133.4 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.69
Genes affected
F9 (HGNC:3551): (coagulation factor IX) This gene encodes vitamin K-dependent coagulation factor IX that circulates in the blood as an inactive zymogen. This factor is converted to an active form by factor XIa, which excises the activation peptide and thus generates a heavy chain and a light chain held together by one or more disulfide bonds. The role of this activated factor IX in the blood coagulation cascade is to activate factor X to its active form through interactions with Ca+2 ions, membrane phospholipids, and factor VIII. Alterations of this gene, including point mutations, insertions and deletions, cause factor IX deficiency, which is a recessive X-linked disorder, also called hemophilia B or Christmas disease. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-139530746-CA-C is Pathogenic according to our data. Variant chrX-139530746-CA-C is described in ClinVar as [Pathogenic]. Clinvar id is 10561.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
F9 | NM_000133.4 | c.-17del | 5_prime_UTR_variant | 1/8 | ENST00000218099.7 | NP_000124.1 | ||
F9 | NM_001313913.2 | c.-17del | 5_prime_UTR_variant | 1/7 | NP_001300842.1 | |||
F9 | XM_005262397.5 | c.-17del | 5_prime_UTR_variant | 1/7 | XP_005262454.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F9 | ENST00000218099.7 | c.-17del | 5_prime_UTR_variant | 1/8 | 1 | NM_000133.4 | ENSP00000218099 | P1 | ||
F9 | ENST00000394090.2 | upstream_gene_variant | 1 | ENSP00000377650 | ||||||
F9 | ENST00000479617.2 | upstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD3 genomes
Cov.:
24
GnomAD4 exome Cov.: 28
GnomAD4 exome
Cov.:
28
GnomAD4 genome Cov.: 24
GnomAD4 genome
Cov.:
24
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Hemophilia B leyden Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 31, 1990 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.